NCT00068276View on ClinicalTrials.gov

Cholecalciferol in Treating Patients With Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

September 30, 2006

Conditions
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Interventions
DIETARY_SUPPLEMENT

cholecalciferol

Trial Locations (1)

27157-1082

Comprehensive Cancer Center at Wake Forest University, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT00068276 - Cholecalciferol in Treating Patients With Myelodysplastic Syndrome | Biotech Hunter | Biotech Hunter